STAT+: Richard Pazdur, longtime cancer regulator, named drug center director at FDA
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
WASHINGTON \u2014 The Food and Drug Administration on Tuesday named Richard Pazdur, its longtime overseer of cancer therapies, as its top drug regulator.\u00a0<\/p>\n
Pazdur replaces former Center for Drug Evaluation and Research Director George Tidmarsh, who exited the agency<\/a> earlier this month amid accusations of using his regulatory authority to advance a personal vendetta against a former business associate, and amid infighting<\/a> with vaccine and biologics center director Vinay Prasad.\u00a0<\/p>\n \u201cDr. Pazdur is a true regulatory innovator who will help guide our broader agenda to modernize the agency and streamline the approval process,\u201d said FDA Commissioner Marty Makary in a statement. \u201cHe has a track record of success and is an impressive forward-thinking scientist.\u201d<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n